Background Dyslipidemia is a modifiable risk factor for cardiovascular disease (CVD). We
investigated the prevalence and associated risk factors of dyslipidemia-raised total …

Background and aims Management of dyslipidemia remains the cornerstone for prevention
of cardiovascular diseases. We aimed to evaluate the epidemiology of dyslipidemia in …

Dyslipidemia is considered a significant modifiable risk factor for type-2 diabetes mellitus
(T2DM) and has become one of the emerging health problems throughout the world. In …

Aim Diabetic dyslipidemia is one of the major risk factors for cardiovascular disease which
has a vast mortality rate throughout the world. Early detection and treatment of dyslipidemia …

Introduction Dyslipidemia is a key clinical abnormality among diabetes mellitus (DM)
patients, which heightens their risk of cardiovascular events. Data on the serum lipid profile …

Background Serum lipid profile abnormalities are major predictors for coronary artery
diseases. The relationship between demographic factors and dyslipidemia in Ethiopia is not …

The present study assessed the prevalence, patterns and determinants of dyslipidaemia
among South African adults with multi-morbidities. In this study, 614 individuals with DM and …

Background Dyslipidaemia is different among patients with hypertension in different
populations. The serum lipid profiles among Hakka patients with hypertension in southern …

Objectives This study aimed to reveal the association between metabolic score for insulin
resistance (MetS-IR) and the risk of mildly decreased estimated glomerular filtration rate …

Objective Diabetes is the most common metabolic disorder that leads to various
complications, and among these complications, disruption in the lipid profile and serum uric …